Mural Oncology (Mural Oncology) Price-to-Tangible-Book : 0.23 (As of Jun. 22, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology Price-to-Tangible-Book?

As of today (2024-06-22), Mural Oncology's share price is $3.23. Mural Oncology's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $13.88. Hence, Mural Oncology's Price to Tangible Book Ratio of today is 0.23.

The historical rank and industry rank for Mural Oncology's Price-to-Tangible-Book or its related term are showing as below:

MURA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.23 Med: 0.36 Max: 0.37
Current: 0.23

During the past 3 years, Mural Oncology's highest Price to Tangible Book Ratio was 0.37. The lowest was 0.23. And the median was 0.36.

MURA's Price-to-Tangible-Book is ranked better than
98.26% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs MURA: 0.23

A closely related ratio is called PB Ratio. As of today, Mural Oncology's share price is $3.23. Mural Oncology's Book Value per Sharefor the quarter that ended in Mar. 2024 was $13.88. Hence, Mural Oncology's P/B Ratio of today is 0.23.

Mural Oncology Price-to-Tangible-Book Historical Data

The historical data trend for Mural Oncology's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology Price-to-Tangible-Book Chart

Mural Oncology Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

0.37

Mural Oncology Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial				-	-	-	0.37	0.35

Competitive Comparison of Mural Oncology's Price-to-Tangible-Book

For the Biotechnology subindustry, Mural Oncology's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mural Oncology's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mural Oncology's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Mural Oncology's Price-to-Tangible-Book falls into.

Mural Oncology Price-to-Tangible-Book Calculation

Mural Oncology's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	3.23	/	13.882
	=	0.23

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Mural Oncology Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Mural Oncology's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Mural Oncology (Mural Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Earlsfort Terrace, Dublin, IRL, D02 T380

Website

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging their core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The Company operates as one business segment, which is the business of developing medicines designed to address unmet medical needs of patients in the area of oncology.

Mural Oncology (Mural Oncology) Headlines

From GuruFocus

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

By Marketwired • 04-24-2024